<?php $root = $_SERVER["DOCUMENT_ROOT"];?>
<?php require $root.'/global/html/header.html';?>
<?php require $root.'/global/html/menu.html';?>

<section style="background:url(img/background.png);background-size:100% 100%;" id="slide_container">
    <h1>Potential Spotlight cost savings<sup>1†</sup></h1>           

<h2>Monomil<sup>®</sup> costs approximately 67% less than Imdur<sup>®</sup>
(isosorbide mononitrate XL 60 mg) which could
deliver costs savings of up to £7.01 (28 pack size)
per prescription. Furthermore, Monomil costs 67%
<span>less (England and Wales) than prescribing
isosorbide mononitrate XL 60 mg tablets
generically.*<sup class="noleft">†</sup></span> <span>At a Primary Care Organisation (PCO)
level, this translates into a potential average
annual saving of over</span> <span>£45,225<sup>1</sup></span></h2>

        <table class="fullscreen">

<thead>
        <tr>
          <th>Spotlight brand</th>
          <th>Annual total number of packs prescribed for Monomil comparable products at equivalent dosage</th>
          <th>Current cost to NHS for Isosorbide mononitrate Prolonged-Release XL 60 mg </th>
          <th>Potential average annual saving to NHS using Monomil written by brand in place of comparable products at equivalent dosage</th>
          <th>Potential average <span class="shiftup">annual saving per PCO<sup>†</sup> using Monomil, if prescribed by brand <span class="table_small_first">(Will be lower in NHS Scotland due 
to drug tariff differences)</span> <span class="table_small" style="top: 10px;"><sup>†</sup>based on 237 PCOs</span></span></th>
          <th>Potential annual saving <span class="shiftuptwo">per average GP practice<sup>‡</sup></span> <span class="shiftall">using Monomil, 
if prescribed by brand <span class="table_small_first">(Will be lower in NHS Scotland due to drug tariff differences)</span> <span class="table_small" style="top: 8px;"><sup>‡</sup>based on 10,339 GP practices</span></span></th>
        </tr>
</thead>
        <tbody>

          <tr class="last">

            <td class="capsorin">Monomil</td>
            <td>3,323,691</td>
            <td>£22,318,065</td>
            <td>£10,718,384</td>
            <td>£45,225</td>
            <td>£1,036.69</td>

          </tr>
 
        </tbody>

        </table>  

  
    <div id="notes">

        <p>*This will be reimbursed at the Cat C price in the Drug
                                Tariff in England and Wales</p>

        <p><sup>†</sup>Cost saving not applicable in NHS Scotland; isosorbide
                                mononitrate 60 mg XL capsules are not available
                                generically, isosorbide mononitrate SR tablets are
                                category R</p>

        <p>An average PCO represents a population of approximately
                                272,000 people. Please note: the term Primary Care
                                Organisation refers to Clinical Commissioning Groups
                                (England), NHS Boards (Scotland), Local Health Boards
                                (Wales) and Health and Social Care Trusts (Northern
                                Ireland)</p>
    </div>

       <p class="side_note">Date of preparation: October 2014  UK/SPL/14/0017i</p>
</section>


<?php require $root.'/global/html/footer.html';?>